InsidersTradesSigma
Total declarations
Company
▲ Purchases (0 ops.)
▼ Sales (0 ops.)
Browse the complete record of transactions filed by Ware Olivia C, Director. Director active across 1 companies, notably Revance Therapeutics, Inc.. Cumulatively, 3 filings have been published. The latest transaction was filed on 4 May 2022 — Attribution. Regulator: SEC (Form 4). The full history is free.
Declarations3 total
06,059 shares0
Common Stock
SEC:0001479290-22-000058:0·
0674 shares0
Common Stock
SEC:0001479290-21-000118·
0674 shares0
Common Stock
SEC:0001479290-21-000118:0·
3 of 3 declarations
About Ware Olivia C
Olivia C. Ware serves as a Director of Revance Therapeutics, Inc. In this role, she participates in the governance of the company and in making strategic decisions. Her experience in the biopharmaceutical sector is an asset for Revance in its innovation efforts.
